Table 2.
Baseline characters of the included population
| Study | Number of patients in each group | Age (months), mean (SD) | Weight (kg), mean (SD) | Height (cm), mean (SD) | Gender (male), N (%) | Baseline heart rate, mean (SD) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| U/S group | Palpation group | U/S group | Palpation group | U/S group | Palpation group | U/S group | Palpation group | U/S group | Palpation group | U/S group | Palpation group | |
| Aktiz-Bıçak et al. 2023 (Femoral) | 20 | 20 | 16.6 ± 10.0 | 14.6 ± 12.6 | 4.8 ± 2.2 | 5.7 ± 2.0 | 57.7 ± 10.3 | 63.4 ± 10.8 | 15 (75) | 14 (70) | 129 ± 11 | 120 ± 17 |
| Aktiz-Bıçak et al. 2023 (IJV) | 26 | 26 | 13.8 ± 14.6 | 15.6 ± 17.3 | 7.3 ± 2.9 | 7.9 ± 3.9 | 69.8 ± 11.6 | 71.7 ± 13.1 | 16 (61.5) | 14 (53.8) | 124 ± 12 | 123 ± 14 |
| Alderson et al. 1993 | 20 | 20 | 8.5 ± 5.6 | 9.2 ± 7.2 | 6.6 ± 2.5 | 6.8 ± 2.5 | N/A | N/A | N/A | N/A | N/A | N/A |
| Aouad et al. 2010 | 24 | 24 | 39.7 ± 30.8 | 29.8 ± 28.3 | 14.3 ± 7.2 | 11 ± 5.5 | 92.2 ± 19.8 | 82 ± 20.5 | 11 (45.8) | 12 (50) | N/A | N/A |
| Grebenik et al. 2004 | 59 | 65 | (1 day to 8 years) | (2 days to 7 years) | 8.6 ± 5.4 | 8.9 ± 6.0 | N/A | N/A | N/A | N/A | N/A | N/A |
| Ishii et al. 2013 | 59 | 59 | 17.8 ± 16.0 | 17.8 ± 16.1 | 8.3 ± 3.4 | 8.3 ± 3.5 | N/A | N/A | N/A | N/A | N/A | N/A |
| Law et al. 2014 | 100 | 101 | 73.2 ± 124.8 | 97.2 ± 168.0 | 22.1 ± 26.1 | 26.2 ± 30 | NA | NA | 40 (40) | 51 (51) | NA | NA |
| Min et al. 2019 | 37 | 37 | 1.7 ± 2.7 | 3.5 ± 3.5 | 4.8 ± 1.9 | 5.7 ± 2.1 | 56.0 ± 7.8 | 60.5 ± 8.1 | 18 (49) | 24 (65) | 153 ± 13 | 146 ± 17 |
| Sadeghi et al. 2022 | 60 | 60 | 30.3 ± 25.9 | 30.3 ± 22.5 | 16.4 ± 24.6 | 11.4 ± 4.8 | 74.4 ± 26.5 | 87.4 ± 19.0 | 30 (50) | 27 (45) | NA | NA |
| Salık et al. 2023 | 20 | 20 | 0.7 ± 0.4 | 0.6 ± 0.3 | 3.5 ± 0.4 | 3.4 ± 0.4 | 51.4 ± 1.9 | 51.2 ± 2.7 | 14 (70) | 15 (70) | 133 ± 15.1 | 130 ± 14.5 |
| Siddik-Sayyid et al. 2016 | 53 | 53 | 37.9 ± 40.4 | 30.6 ± 25.7 | 10.6 ± 4.8 | 12.4 ± 8.0 | 82.7 ± 18.2 | 86.3 ± 26.1 | 33 (62.3) | 29 (54.7) | 116 ± 20.4 | 116 ± 20.6 |
| Verghese et al. 1999 | 43 | 52 | 6.4 ± 3.8 | 5.9 ± 4.4 | 6.0 ± 2.3 | 5.8 ± 2.0 | NA | NA | NA | NA | NA | NA |
| Verghese et al. 2000 | 16 | 16 | 8.0 ± 5.9 | 5.4 ± 4.1 | 6.0 ± 1.8 | 6.4 ± 2.3 | NA | NA | NA | NA | NA | NA |
| Study | Baseline SBP (mmHg), mean (SD) | Baseline DBP (mmHg), mean (SD) | Baseline CVP (mmHg), mean (SD) | Vessel diameter (mm), mean (SD) | Previous cannulation, N (%) | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| U/S group | Palpation group | U/S group | Palpation group | U/S group | Palpation group | U/S group | Palpation group | U/S group | Palpation group | |
| Aktiz-Bıçak et al. 2023 (Femoral) | 69 ± 21 | 81 ± 19 | 40 ± 16 | 44 ± 12 | 4.7 ± 2.8 | 3.9 ± 3.2 | 2.0 ± 0.3 | 2.2 ± 0.4 | 13 (65) | 16 (80) |
| Aktiz-Bıçak et al. 2023 (IJV) | 87 ± 14 | 82 ± 14 | 50 ± 10 | 46 ± 8 | 4.6 ± 3.5 | 4.3 ± 3.0 | 5.7 ± 1.2 | 6.1 ± 0.9 | 6 (23.1) | 6 (23.1) |
| Alderson et al. 1993 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0 (0) | 0 (0) |
| Aouad et al. 2010 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Grebenik et al. 2004 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Ishii et al. 2013 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Law et al. 2014 | NA | NA | NA | NA | NA | NA | NA | NA | 39 (39) | 43 (42.6) |
| Min et al. 2019 | 57 ± 16 | 62 ± 17 | NA | NA | NA | NA | 1.3 ± 0.6 | 1.3 ± 0.4 | NA | NA |
| Sadeghi et al. 2022 | NA | NA | NA | NA | NA | NA | NA | NA | 39 (65) | 43 (71.7) |
| Salık et al. 2023 | 57.9 ± 11.3 | 65.3 ± 17.0 | 32.2 ± 9.6 | 35.7 ± 12.9 | 4.7 ± 2.7 | 4.7 ± 2.7 | 1.9 ± 0.2 | 1.9 ± 0.2 | 13 (65) | 16 (80) |
| Siddik-Sayyid et al. 2016 | 94.3 ± 14.4 | 94.3 ± 17.7 | 57 ± 12.4 | 57 ± 12.4 | NA | NA | 3.2 ± 1.2 | 3.3 ± 1.1 | NA | NA |
| Verghese et al. 1999 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| Verghese et al. 2000 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |